ASCO Updates Biomarkers for Breast Cancer Tx Guidance

This article originally appeared here.
Share this content:
ASCO Updates Biomarkers for Breast Cancer Tx Guidance
ASCO Updates Biomarkers for Breast Cancer Tx Guidance

THURSDAY, Feb. 11, 2016 (HealthDay News) -- The American Society of Clinical Oncology has updated recommendations on the use of biomarkers to guide decisions on adjuvant systemic therapy for women with early-stage invasive breast cancer. The clinical practice guideline was published online Feb. 8 in the Journal of Clinical Oncology.

Lyndsay N. Harris, M.D., from the Case Western Reserve University in Cleveland, and colleagues on the expert panel conducted a literature search to identify studies (published from 2006 to 2014) with outcomes of overall survival and disease-free or recurrence-free survival. Informal consensus of the panel members was used to develop evidence-based guideline recommendations.

The panel found that 19 of 50 relevant studies evaluated clinical utility. However, no studies that met guideline criteria for clinical utility were found to guide choice of specific treatments or regimens. The panel notes that in addition to estrogen and progesterone receptors and human epidermal growth factor receptor 2, there is sufficient evidence of clinical utility for the biomarker assays Oncotype DX, EndoPredict, PAM50, Breast Cancer Index, and urokinase plasminogen activator and plasminogen activator inhibitor type 1 in specific subgroups of breast cancer.

"Treatment decisions should also consider disease stage, comorbidities, and patient preferences," the authors write.

Abstract
Full Text

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

Pharmacists Should Counsel Patients Fasting for Ramadan

Pharmacists Should Counsel Patients Fasting for Ramadan

Pharmacists can suggest adjustments for meds taken several times per day, those affected by food intake

AUA: Many Have Unused Opioids After Urologic Procedures

AUA: Many Have Unused Opioids After Urologic Procedures

Patients use just over half of initial prescription; highest percentage of unused meds for cystectomy

Over Half of Young Adult Smoke Volume Exposure From Hookahs

Over Half of Young Adult Smoke Volume Exposure ...

Toxicant exposure to tar, carbon monoxide, nicotine lower, but still substantial, compared to cigarettes

is free, fast, and customized just for you!

Already a member?

Sign In Now »